家族性渗出性玻璃体视网膜病变患者LRP5基因突变研究

doi:10.16288/j.yczz.16-339

遗传 ›› 2017, Vol. 39 ›› Issue (3): 241-249.doi: 10.16288/j.yczz.16-339

家族性渗出性玻璃体视网膜病变患者LRP5基因突变研究

刘玉庆^1,3, 朱雄^1,3, 李姝锦⁴, 杨业明^1,3, 杨牧^1,4, 赵培泉², 朱献军^1,3,4

1. 电子科技大学医学院,电子科技大学附属医院,四川省人民医院人类疾病基因研究四川省重点实验室,成都 610072;
2. 上海交通大学医学院附属新华医院眼科学系,上海 200092;
3. 四川省医学科学院,四川省人民医院实验动物研究所,成都 610212;
4. 中国科学院成都生物研究所,成都 610042

收稿日期:2016-10-16 修回日期:2017-01-18 出版日期:2017-03-20 发布日期:2017-02-23
通讯作者: 朱献军,研究员,博士生导师,研究方向：疾病基因研究。E-mail: xjzhu@uestc.edu.cn
作者简介:刘玉庆,硕士研究生,专业方向：生物医学工程。E-mail: liuyuqing610@yeah.net,朱雄,博士研究生,专业方向：生物医学工程。E-mail: zhuxiong7555711@163.com,刘玉庆和朱雄为并列第一作者。
基金资助:
国家自然科学基金项目(编号：81470668, 81271007)和四川省科技厅项目(编号：2014JQ0023, 2016TD0009)资助

Identification of LRP5 mutations in families with familial exudative vitreoretinopathy

Liu Yuqing^1,3, Zhu Xiong^1,3, Li Shujin⁴, Yang Yeming^1,3, Yang Mu^1,4, Zhao Peiquan², Zhu Xianjun^1,3,4

1. Sichuan Provincial Key Laboratory for Human Disease Gene Study, Hospital of the University of Electronic Science and Technology of China and Sichuan Provincial People's Hospital, Chengdu 610072, China;
2. Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China;
3. Institute of Laboratory Animal Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu 610212 China;
4. Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610042, China

Received:2016-10-16 Revised:2017-01-18 Online:2017-03-20 Published:2017-02-23
Supported by:
Supported by the National Natural Science Foundation of China (Nos; 81470668, 81271007) and Sichuan Science and Technology Department project (Nos; 2014JQ0023, 2016TD0009)

摘要/Abstract

摘要： 家族性渗出性玻璃体视网膜病变(familial exudative vitreoretinopathy, FEVR)是一种遗传性眼科疾病,主要特征为视网膜周边血管发育异常和病变。由于病变程度不同,临床表型可从无明显症状到眼睛完全失明。本文通过研究3个中国FEVR家系和1个散发型患者,探索其致病突变与疾病表型之间的关系。收集家系中患者及亲属的外周血制备基因组DNA,设计引物以扩增FEVR致病基因FZD4、LRP5、NDP和TSPAN12的外显子区域并通过Sanger法进行测序。结果发现,在LRP5基因上存在3个未在dbSNP数据库及千人基因组计划数据库中报道过的杂合突变p.M181R、p.R399S和p.G503R,以及2个已发现但未在FEVR中报道过的杂合突变p.R494Q和p.G876S。生物信息学分析表明这5个突变位点均高度保守,为有害突变。荧光素酶报告基因实验证明了这5个突变均不能激活Norrin/β-catenin信号通路,进一步证明了这5个突变的致病性。该研究扩充了我国FEVR疾病的遗传数据库,可为该疾病的分子诊断提供依据。

关键词: 家族性渗出性玻璃体视网膜病变, 低密度脂蛋白受体相关蛋白5, 基因突变

Abstract: Familial exudative vitreoretinopathy (FEVR) is a hereditary eye disease characterized by defects in the development of periphery retinal vessels. However, the clinical phenotypes of FEVR vary widely from asymptomatic to complete blindness. We analyzed patients from three Chinese families and one sporadic patient with FEVR to investigate the clinical features and disease-causing mutations. Ocular phenotypes included increased ramification of the peripheral retinal vessels, a peripheral avascular zone, inferotemporal dragging of the optic disc and macula, and retinal folds. Peripheral blood DNA samples were obtained from patients with FEVR and their family members. Primers were designed to amplify the coding exons and adjacent intronic regions of the FEVR-causing genes FZD4, LRP5, NDP and TSPAN12. By polymerase chain reactions, each amplicon was subjected to direct Sanger sequencing analysis. Potential pathogenic changes of the sequence variants were analyzed by the orthologous protein sequence alignment and computational prediction software. We identified five LRP5 mutations: three novel heterozygous mutations-p.M181R, p.R399S and p.G503R and two known mutations that were never reported in FEVR patients: p.R494Q and p.G876S. All five mutations involved highly conserved residues and were predicted to be damaging by SIFT and PolyPhen-2. None was present in 500 normal individuals. To assess the pathogenesis of these mutations, wild-type and all five mutant LRP5 proteins were assayed for the ability to activate the Norrin/β-catenin pathway by established luciferase reporter assays, and all mutants failed to activate the pathway. This study extends the genetic database of the FEVR disease in China and provides a basis for molecular diagnosis of the disease.

Key words: familial exudative vitreoretinopathy (FEVR), low density lipoprotein receptor related protein-5 (LRP5), gene mutation

刘玉庆, 朱雄, 李姝锦, 杨业明, 杨牧, 赵培泉, 朱献军. 家族性渗出性玻璃体视网膜病变患者LRP5基因突变研究[J]. 遗传, 2017, 39(3): 241-249.

Liu Yuqing, Zhu Xiong, Li Shujin, Yang Yeming, Yang Mu, Zhao Peiquan, Zhu Xianjun. Identification of LRP5 mutations in families with familial exudative vitreoretinopathy[J]. Hereditas(Beijing), 2017, 39(3): 241-249.

参考文献

[1] Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol , 1969, 68(4): 578-594.
[2] Canny CL, Oliver GL. Fluorescein angiographic findings in familial exudative vitreoretinopathy. Arch Ophthalmol , 1976, 94(7): 1114-1120.
[3] Vannouhuys CE. Dominant exudative vitreoretinopathy. Ophthalmic Paediatr Genet , 1985, 5(1-2): 31-38.
[4] Feldman EL, Norris JL, Cleasby GW. Autosomal dominant exudative vitreoretinopathy. Arch Ophthalmol , 1983, 101(10): 1532-1535.
[5] Gow J, Oliver GL. Familial exudative vitreoretinopathy. An expanded view. Arch Ophthalmol , 1971, 86(2): 150-155.
[6] de Crecchio G, Simonelli F, Nunziata G, Mazzeo S, Greco GM, Rinaldi E, Ventruto V, Ciccodicola A, Miano MG, Testa F, Curci A, D'Urso M, Rinaldi MM, Cavaliere ML, Castelluccio P. Autosomal recessive familial exudative vitreoretinopathy: evidence for genetic heterogeneity. Clin Genet , 1998, 54(4): 315-320.
[7] Shastry BS, Trese MT. Familial exudative vitreoretinopathy: further evidence for genetic heterogeneity. Am J Med Genet , 1997, 69(2): 217-218.
[8] Chen ZY, Battinelli EM, Fielder A, Bundey S, Sims K, Breakefield XO, Craig IW. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet , 1993, 5(2): 180-183.
[9] Plager DA, Orgel IK, Ellis FD, Hartzer M, Trese MT, Shastry BS. X-linked recessive familial exudative vitreoretinopathy. Am J Ophthalmol , 1992, 114(2): 145-148.
[10] Berger W, van de Pol D, Warburg M, Gal A, Bleeker-Wagemakers L, de Silva H, Meindl A, Meitinger T, Cremers F, Ropers HH. Mutations in the candidate gene for Norrie disease. Hum Mol Genet , 1992, 1(7): 461-465.
[11] Shastry BS, Hejtmancik JF, Hiraoka M, Ibaraki N, Okubo Y, Okubo A, Han DP, Trese MT. Linkage and candidate gene analysis of autosomal-dominant familial exudative vitreoretinopathy. Clin Genet , 2000, 58(4): 329-332.
[12] Kondo H, Ohno K, Tahira T, Hayashi H, Oshima K, Hayashi K. Delineation of the critical interval for the familial exudative vitreoretinopathy gene by linkage and haplotype analysis. Hum Genet , 2001, 108(5): 368-375.
[13] Fei P, Zhu X, Jiang ZL, Ma S, Li J, Zhang Q, Zhou Y, Xu Y, Tai ZF, Zhang L, Huang LL, Yang ZL, Zhao PQ, Zhu XJ. Identification and functional analysis of novel FZD4 mutations in Han Chinese with familial exudative vitreoretinopathy. Sci Rep , 2015, 5: 16120.
[14] Robitaille J, MacDonald MLE, Kaykas A, Sheldahl LC, Zeisler J, Dubé MP, Zhang LH, Singaraja RR, Guernsey DL, Zheng BY, Siebert LF, Hoskin-Mott A, Trese MT, Pimstone SN, Shastry BS, Moon RT, Hayden MR, Goldberg YP, Samuels ME. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat Genet , 2002, 32(2): 326-330.
[15] Jiao XD, Ventruto V, Trese MT, Shastry BS, Hejtmancik JF. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5 . Am J Hum Genet , 2004, 75(5): 878-884.
[16] Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, Mackey DA, Craig JE, Jiang L, Yang ZL, Trembath R, Woodruff G, Gregory-Evans CY, Gregory-Evans K, Parker MJ, Black GCM, Downey LM, Zhang K, Inglehearn CF. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet , 2004, 74(4): 721-730.
[17] Xu Y, Huang LL, Li J, Zhang Q, Fei P, Zhu X, Tai ZF, Ma S, Gong B, Li Y, Zang WZ, Zhu XJ, Zhao PQ, Yang ZL. Novel mutations in the TSPAN12 gene in Chinese patients with familial exudative vitreoretinopathy. Mol Vis , 2014, 20: 1296-1306.
[18] Collin RWJ, Nikopoulos K, Dona M, Gilissen C, Hoischen A, Boonstra FN, Poulter JA, Kondo H, Berger W, Toomes C, Tahira T, Mohn LR, Blokland EA, Hetterschijt L, Ali M, Groothuismink JM, Duijkers L, Inglehearn CF, Sollfrank L, Strom TM, Uchio E, van Nouhuys CE, Kremer H, Veltman JA, van Wijk E, Cremers FPM. ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zeb

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

家族性渗出性玻璃体视网膜病变患者LRP5基因突变研究

Identification of LRP5 mutations in families with familial exudative vitreoretinopathy

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	宋绍征, 何正义, 成勇, 于宝利, 张婷, 李丹. TALENs介导MSTN基因突变山羊的制备及性能分析[J]. 遗传, 2022, 44(6): 531-542.
[2]	贾觉睿智, 肖诚, 刘艺文, 李冉, 张化冰, 于淼. 二例GCK基因突变致先天性高胰岛素性低血糖症的诊疗和基因检测分析[J]. 遗传, 2022, 44(11): 1056-1062.
[3]	肖诚, 刘洁颖, 杨春如, 于淼. LMNA基因突变相关脂肪萎缩综合征的研究进展[J]. 遗传, 2022, 44(10): 913-925.
[4]	蒋琬姿, 张丽雯, 贺彩红, 阮梅花, 季勇, 于建荣, 周红文. 家族性高胆固醇血症研究进展[J]. 遗传, 2021, 43(11): 1011-1022.
[5]	朱海美, 黄鹏程, 赵田田, 周长慧, 李若婉, 于春荣, 陈志勇, 顾林峰, 常艳. 纳米银颗粒及纳米二氧化钛颗粒的体外遗传毒性研究[J]. 遗传, 2020, 42(12): 1192-1200.
[6]	孙兆庆, 闫波. 转录因子GATA6在心血管疾病中的作用及其调控机制[J]. 遗传, 2019, 41(5): 375-383.
[7]	李楠, 李亚娟, 郭海滨, 张向前. Ds插入突变体的遗传学综合性实验设计与探讨[J]. 遗传, 2019, 41(12): 1148-1155.
[8]	徐福如, 蒋文君, 张涛, 姜倩, 张瑞雪, 毕宏生. FBN2基因突变与遗传性结缔组织病的发生[J]. 遗传, 2019, 41(10): 919-927.
[9]	严婷婷, 张蕾, 李余动, 梁新乐. 基于微信的“微生物遗传育种实验”混合式教学模式探究[J]. 遗传, 2018, 40(7): 601-606.
[10]	邹永新,龚瑶琴. 影响RNA剪接的基因变异[J]. 遗传, 2017, 39(3): 200-207.
[11]	孙帅, 邓宇亮. 肺癌循环肿瘤细胞的单细胞EGFR基因突变检测[J]. 遗传, 2015, 37(12): 1251-1257.
[12]	刘亚兰, 张华, 冯永. 神经嵴发育异常导致综合征型耳聋的机制[J]. 遗传, 2014, 36(11): 1131-1144.
[13]	何轶群许美芬于涵耿军伟施苏雪薛凌卢中秋管敏鑫. 血脂异常遗传性疾病的研究现状[J]. 遗传, 2013, 35(11): 1237-1243.
[14]	李宗斌，刘昱圻，李彦华，陈瑞，王琳，朱庆磊，李泱，王士雯. 中国汉族原发性高血压患者线粒体tRNA基因突变[J]. 遗传, 2011, 33(6): 601-606.
[15]	代艳芳，孙立元，张新波，王绿娅. 中国人群家族性高胆固醇血症LDLR基因突变研究进展[J]. 遗传, 2011, 33(1): 1-8.